This site uses cookies to ensure the best viewing experience for our readers. Read more about it Got it

Brief

CEO of Burn Treatment Company MediWound Steps Down

Following a 12-year tenure, Gal Cohen will be replaced by the company’s current chief financial officer Sharon Malka in late May

CTech 13:0214.03.19
CEO of Nasdaq-listed biopharmaceutical company MediWound Ltd. Gal Cohen is stepping down from his position after a 12-year tenure, the company announced Tuesday. Cohen will be replaced in late May by the company’s current chief financial officer Sharon Malka.

 

Founded in 2001 and based in Yavne, a town central Israel, MediWound develops and manufactures treatments for severe burns and chronic wounds. The company’s flagship product is a pineapple enzyme-based treatment used for the removal of dead tissue from burn wounds.

 

Retiring MediWound CEO Gal Cohen (left) with appointed CEO Sharon Malka. Photo: PR Retiring MediWound CEO Gal Cohen (left) with appointed CEO Sharon Malka. Photo: PR

 

Cancel Send
    To all comments